Dana Minnick

Dana Minnick possesses extensive experience in regulatory science and drug development, currently serving as an Advisor at SciLucent, Inc. since 2019. Prior to this, Dana held the position of Senior Regulatory Scientist at Rho, contributing to business development and program management while leading teams and analyzing program-related issues. Dana's career includes roles such as Drug Development Regulatory Program Leader at RTI International, where guidance through marketing authorization was provided, and as a Consultant at Aclairo Pharmaceutical Development Group, focusing on regulatory submissions. Additionally, Dana has held significant positions at Viamet Pharmaceuticals, Calvert Research, GSK, Paradigm Genetics, and Hoescht Celanese Fibers Operations, covering various aspects of drug development, safety assessment, project management, and toxicology. Educational qualifications include a PhD in Toxicology from Case Western Reserve University School of Medicine and a BA in Biology from Case Western Reserve University.